Chemistry and structure-activity relationship of the styrylquinoline-type HIV integrase inhibitors.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Jean-François Mouscadet, Didier Desmaële

Abstract

In spite of significant progress in anti-HIV-1 therapy, current antiviral chemo-therapy still suffers from deleterious side effects and emerging drug resistance. Therefore, the development of novel antiviral drugs remains a crucial issue for the fight against AIDS. HIV-1 integrase is a key enzyme in the replication cycle of the retrovirus since it catalyzes the integration of the reverse transcribed viral DNA into the chromosomal DNA. Efforts to develop anti-integrase drugs started during the early nineties, culminating with the recent approval of Raltegravir. The discovery and the development of the styrylquinoline inhibitor class was an important step in the overall process. In this review we have described the key synthetic issues and the structure-activity relationship of this family of integrase inhibitors. Crystallographic and docking studies that shed light on their mechanism of action are also examined.

References

Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y GoldgurD R Davies
May 23, 2000·Journal of Medicinal Chemistry·M OualiM Le Bret
Oct 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·A S EspesethD J Hazuda
Sep 5, 2002·Archiv der Pharmazie·Jae Yeol LeeYong Sup Lee
Oct 4, 2002·Journal of Medicinal Chemistry·Jaroslaw PolanskiMarc Le Bret
Dec 13, 2002·Journal of Medicinal Chemistry·Alexander L Perryman, J Andrew McCammon
Mar 15, 2003·The New England Journal of Medicine·Jacob P LalezariUNKNOWN TORO 1 Study Group
Jan 15, 2004·Molecular Pharmacology·Eric DeprezJean-François Mouscadet
Apr 28, 2004·Bioorganic & Medicinal Chemistry Letters·Christophe BénardJean d'Angelo
Jul 13, 2004·Molecular Pharmacology·Aurélie MousnierCatherine Dargemont
Feb 25, 2005·Nature Reviews. Drug Discovery·Yves PommierChristophe Marchand
Nov 18, 2005·Advances in Genetics·Mary K Lewinski, Frederic D Bushman
Feb 14, 2006·The Journal of Physical Chemistry. B·Delphine FirleyNour Eddine Ghermani
Mar 24, 2006·Bioorganic & Medicinal Chemistry Letters·James P GuareSteven D Young
Jan 30, 2008·Antimicrobial Agents and Chemotherapy·Isabelle MaletAnne-Geneviève Marcelin
Apr 24, 2009·Expert Opinion on Pharmacotherapy·Lisa M ChirchRoy T Steigbigel
Jun 2, 2009·Antiviral Chemistry & Chemotherapy·Hans-Jürgen Stellbrink
Jun 19, 2009·Therapeutics and Clinical Risk Management·Christine Katlama, Robert Murphy
Nov 11, 2009·Antimicrobial Agents and Chemotherapy·Olivier DelelisJean-François Mouscadet
Nov 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Gabriele B Beck-EngeserMatthias Wabl
Feb 26, 2010·Expert Opinion on Therapeutic Patents·Hanbiao Yang, David M Rotstein

❮ Previous
Next ❯

Citations

Sep 21, 2012·SAR and QSAR in Environmental Research·X H SunC X Wang
Jan 12, 2011·Antimicrobial Agents and Chemotherapy·Philippe M LoiseauDidier Desmaele
Mar 23, 2011·Biochemistry. Biokhimii︠a︡·M I ZverevaO A Dontsova
Sep 26, 2014·Chemical Reviews·Hidayat HussainSimon Gibbons
Jul 13, 2013·Pharmaceutical Biology·Areerat SuedeePharkphoom Panichayupakaranant
Jul 20, 2011·Bioorganic & Medicinal Chemistry·Katarzyna SerafinJaroslaw Polanski
Jul 23, 2013·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Pan NingJinglai Zhang
May 19, 2016·European Journal of Medicinal Chemistry·Valentina Oliveri, Graziella Vecchio
Jun 5, 2019·Medicinal Chemistry·Robert Musiol
Jun 28, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Song Thi LeNagatoshi Nishiwaki
Dec 13, 2019·Expert Opinion on Drug Discovery·Ivana M Savić-Gajić, Ivan M Savić
Sep 8, 2018·Chemical Reviews·Allie Y ChenSeth M Cohen
Aug 2, 2018·Organic Letters·Nadine ZumbrägelHarald Gröger

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
nuclear translocation

Software Mentioned

INSTIs

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.